|
Kabra Drugs Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
46.09 Cr.
|
P/BV
|
1.87
|
Book Value (Rs.)
|
10.40
|
|
52 Week High/Low (Rs.)
|
23/10
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Employees Cost | 0.44 | 0.28 | 0.15 | 0.05 | 0.00 |
| Other Expenses | 1.04 | 0.09 | 0.05 | 0.08 | 0.04 |
| Total Expenses | 1.48 | 0.37 | 0.20 | 0.13 | 0.04 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.48 | -0.37 | -0.20 | -0.13 | -0.04 |
| Other Income | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| P/L Before Interest, Excpt. Items & Tax | -1.48 | -0.37 | -0.20 | -0.13 | -0.04 |
| P/L Before Exceptional Items & Tax | -1.48 | -0.37 | -0.20 | -0.13 | -0.04 |
| P/L Before Tax | -1.48 | -0.37 | -0.20 | -0.13 | -0.04 |
| P/L After Tax from Ordinary Activities | -1.48 | -0.37 | -0.20 | -0.13 | -0.04 |
| Net Profit/Loss For the Period | -1.48 | -0.37 | -0.20 | -0.13 | -0.04 |
| | | | | | |
| Equity Share Capital | 10.08 | 4.39 | 4.39 | 4.39 | 4.39 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -1.47 | -0.83 | -0.45 | -0.30 | -0.09 |
| Diluted EPS (Rs.) | -1.47 | -0.83 | -0.45 | -0.30 | -0.09 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -1.47 | -0.83 | -0.45 | -0.30 | -0.09 |
| Diluted EPS (Rs.) | -1.47 | -0.83 | -0.45 | -0.30 | -0.09 |
